US Stock MarketDetailed Quotes
ACER ACER THERAPEUTICS INC
- 0.660
- 0.0000.00%
15min DelayClose Nov 20 16:00 ET
16.15MMarket Cap-342P/E (TTM)
0.000High0.000Low0Volume0.660Open0.660Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)24.46MShares0.66052wk High-0.49P/B12.49MFloat Cap0.66052wk Low--Dividend TTM18.92MShs Float0.660Historical High--Div YieldTTM0.00%Amplitude0.660Historical Low--Avg Price1Lot Size
ACER THERAPEUTICS INC Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 44.14%-5.5M | -199.27%-9.02M | -22,323.93%-30.25M | -484.28%-8.3M | -14.20%-9.09M | -257.95%-9.85M | -200.27%-3.01M | 99.21%-134.91K | 63.39%-1.42M | -78.94%-7.96M |
| Net income from continuing operations | -203.36%-8.09M | -77.37%-16.28M | -70.66%-26.24M | -112.28%-9.38M | -52.98%-5.01M | 13.10%-2.67M | -99.05%-9.18M | 32.82%-15.37M | 29.13%-4.42M | 44.79%-3.27M |
| Operating gains losses | --487.9K | --8.19M | 100.82%4.67K | --0 | --0 | ---- | ---- | -14,390.61%-568.91K | --0 | --0 |
| Depreciation and amortization | -45.42%9.93K | -24.55%15.55K | -6.88%66.04K | -32.68%13.25K | -24.76%13.99K | 1.04%18.19K | 40.81%20.61K | 0.14%70.91K | 10.88%19.69K | 5.38%18.59K |
| Other non cash items | 161.96%2.81M | 30.91%2.79M | --1.47M | --4.08M | ---202.15K | -328,788.75%-4.53M | 154,505.59%2.13M | ---- | ---- | ---- |
| Change In working capital | 68.86%-977.73K | -213.50%-4.02M | -155.02%-7.4M | -240.87%-3.45M | 17.89%-4.35M | -133.90%-3.14M | -49.71%3.54M | 336.51%13.45M | 39.87%2.45M | -643.86%-5.3M |
| -Change in receivables | --0 | --0 | 200.00%5M | --0 | --0 | --0 | 150.00%5M | ---5M | ---5M | --0 |
| -Change in inventory | ---4.19M | ---412.04K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Change in prepaid assets | -74.68%217.44K | 90.37%-41.49K | 180.75%334.94K | 1,199.45%161.42K | 62.51%-254.39K | 238.44%858.7K | -17,954.78%-430.79K | -491.77%-414.77K | -92.56%12.42K | -72.49%-678.53K |
| -Change in payables and accrued expense | 452.46%5M | -139.78%-1.72M | 305.26%3.32M | -310.13%-1.39M | -281.47%-513.71K | 38.72%904.98K | 254.44%4.32M | -154.93%-1.62M | -58.32%660.85K | -110.06%-134.67K |
| -Change in other current assets | -100.20%-1.5K | -99.83%14.67K | 200.16%9.28M | -120.61%-11.92K | 7.65%77.06K | 76.68%759.99K | 186.06%8.46M | -42,171.13%-9.27M | 117,942.86%57.84K | 225.76%71.59K |
| -Change in other current liabilities | --0 | --0 | -200.03%-9.27M | -1,372.06%-24.27K | 63.82%-50.57K | -67.64%-757.44K | -185.60%-8.43M | 162,977.83%9.26M | 193.58%1.91K | -1,911.05%-139.8K |
| -Change in other working capital | 59.14%-2M | 65.35%-1.86M | -178.46%-16.07M | -132.54%-2.19M | 18.29%-3.61M | -202.37%-4.91M | -127.11%-5.37M | --20.49M | --6.72M | ---4.42M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 44.14%-5.5M | -199.27%-9.02M | -22,323.93%-30.25M | -484.28%-8.3M | -14.20%-9.09M | -257.95%-9.85M | -200.27%-3.01M | 99.21%-134.91K | 63.39%-1.42M | -78.94%-7.96M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 89.40%-3.07K | -211.54%-171.17K | -560.60%-135.33K | 74.50%-4.91K | 79.75%-2.01K | -443.59%-28.93K | -403.98%-54.94K | -136.20%-20.49K | -762.99%-19.24K |
| Net PPE purchase and sale | --0 | 89.40%-3.07K | -211.54%-171.17K | -560.60%-135.33K | 74.50%-4.91K | 79.75%-2.01K | -443.59%-28.93K | -403.98%-54.94K | -136.20%-20.49K | -762.99%-19.24K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 89.40%-3.07K | -211.54%-171.17K | -560.60%-135.33K | 74.50%-4.91K | 79.75%-2.01K | -443.59%-28.93K | -403.98%-54.94K | -136.20%-20.49K | -762.99%-19.24K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -80.77%677.63K | 17.43%13.07M | 180.73%20.04M | 4.38M | 1M | 3.52M | 55.93%11.13M | -33.42%7.14M | 0 | 0 |
| Net issuance payments of debt | -31.21%498.66K | -40.50%6.43M | 170.12%10.8M | ---724.93K | --0 | --724.93K | 170.12%10.8M | 611.14%4M | --0 | --0 |
| Net common stock issuance | -90.14%347.61K | --6.17M | 183.84%8.91M | --4.38M | --1M | --3.52M | --0 | -69.10%3.14M | --0 | --0 |
| Proceeds from stock option exercised by employees | --585 | 44.48%472.5K | --327.03K | --0 | --0 | --0 | --327.03K | --0 | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -80.77%677.63K | 17.43%13.07M | 180.73%20.04M | --4.38M | --1M | --3.52M | 55.93%11.13M | -33.42%7.14M | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -69.33%6.38M | -81.68%2.33M | 120.61%12.71M | -54.93%6.38M | -34.61%14.47M | 30.82%20.8M | 120.61%12.71M | -52.30%5.76M | 129.83%14.15M | 276.28%22.13M |
| Current changes in cash | 23.76%-4.83M | -49.93%4.05M | -249.39%-10.38M | -181.02%-4.05M | -1.44%-8.09M | -201.65%-6.33M | -20.21%8.09M | 210.02%6.95M | -263.93%-1.44M | -2,984.02%-7.98M |
| End cash Position | -89.26%1.55M | -69.33%6.38M | -81.68%2.33M | -81.68%2.33M | -54.93%6.38M | -34.61%14.47M | 30.82%20.8M | 120.61%12.71M | 120.61%12.71M | 129.83%14.15M |
| Free cash flow | 44.15%-5.5M | -196.53%-9.02M | -15,924.54%-30.42M | -485.37%-8.43M | -13.99%-9.09M | -258.23%-9.85M | -201.42%-3.04M | 98.89%-189.85K | 62.95%-1.44M | -79.28%-7.98M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg